In three separate trials, the drug flibanserin did wonders for women’s flagging sex drive despite doing nothing to lift mood. Since Viagra’s launch in 1998, more than two dozen experimental therapies have been studied for so-called “female sexual dysfunction,” a market worth an estimated $2 billion but despite massive financial investment flibanserin has also been turned down by the US FDA. Read the full story here.